News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
426,468 Results
Type
Article (48605)
Company Profile (84)
Press Release (377774)
Multimedia
Podcasts (32)
Webinars (14)
Section
Business (118887)
Career Advice (1334)
Deals (16776)
Drug Delivery (49)
Drug Development (50243)
Employer Resources (94)
FDA (8507)
Job Trends (9306)
News (194690)
Policy (15307)
Tag
2027 Pharm Country Standard (1)
Academia (2644)
Academic (1)
Accelerated approval (19)
Adcomms (11)
Allergies (73)
Alliances (34345)
ALS (121)
Alzheimer's disease (1364)
Antibody-drug conjugate (ADC) (191)
Approvals (8674)
Artificial intelligence (355)
Autoimmune disease (98)
Automation (17)
Bankruptcy (103)
Best Places to Work (7228)
BIOSECURE Act (11)
Biosimilars (66)
Biotechnology (54)
Bladder cancer (80)
Brain cancer (49)
Breast cancer (420)
Cancer (3237)
Cardiovascular disease (212)
Career advice (1126)
Career pathing (27)
CAR-T (195)
CDC (27)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (17)
Clinical research (41451)
Collaboration (1287)
Compensation (151)
Complete response letters (23)
COVID-19 (1983)
CRISPR (72)
C-suite (464)
Cystic fibrosis (101)
Data (4154)
Decentralized trials (2)
Denatured (11)
Depression (82)
Diabetes (286)
Diagnostics (4088)
Digital health (22)
Diversity (6)
Diversity, equity & inclusion (25)
Drug discovery (201)
Drug pricing (81)
Drug shortages (6)
Duchenne muscular dystrophy (137)
Earnings (45314)
Editorial (34)
Employer branding (14)
Employer resources (85)
Events (52147)
Executive appointments (601)
FDA (10267)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (4)
Frontotemporal dementia (14)
Funding (943)
Gene editing (130)
Generative AI (31)
Gene therapy (371)
GLP-1 (513)
Government (2471)
Grass and pollen (2)
Guidances (314)
Healthcare (11192)
HIV (37)
Huntington's disease (23)
IgA nephropathy (34)
Immunology and inflammation (115)
Immuno-oncology (34)
Indications (67)
Infectious disease (2140)
Inflammatory bowel disease (120)
Inflation Reduction Act (6)
Influenza (73)
Intellectual property (145)
Interviews (263)
IPO (7739)
IRA (33)
Job creations (2331)
Job search strategy (960)
JPM (24)
Kidney cancer (8)
Labor market (57)
Layoffs (321)
Leadership (15)
Legal (2829)
Liver cancer (41)
Longevity (9)
Lung cancer (413)
Lymphoma (265)
Machine learning (32)
Management (29)
Manufacturing (439)
MASH (109)
Medical device (6461)
Medtech (6484)
Mergers & acquisitions (9634)
Metabolic disorders (644)
Multiple sclerosis (112)
NASH (11)
Neurodegenerative disease (215)
Neuropsychiatric disorders (45)
Neuroscience (2204)
Neurotech (1)
NextGen: Class of 2026 (3490)
Non-profit (3674)
Now hiring (45)
Obesity (240)
Opinion (184)
Ovarian cancer (131)
Pain (104)
Pancreatic cancer (139)
Parkinson's disease (218)
Partnered (24)
Patents (256)
Patient recruitment (285)
Peanut (34)
People (36429)
Pharmaceutical (18)
Pharmacy benefit managers (10)
Phase 1 (12944)
Phase 2 (17686)
Phase 3 (13940)
Pipeline (3636)
Policy (171)
Postmarket research (1901)
Preclinical (7085)
Press Release (65)
Prostate cancer (171)
Psychedelics (27)
Radiopharmaceuticals (181)
Rare diseases (503)
Real estate (3976)
Recruiting (38)
Regulatory (12389)
Reports (33)
Research institute (2579)
Resumes & cover letters (192)
Rett syndrome (15)
RNA editing (6)
RSV (38)
Schizophrenia (102)
Series A (121)
Series B (83)
Service/supplier (10)
Sickle cell disease (66)
Special edition (16)
Spinal muscular atrophy (110)
Sponsored (30)
Startups (2295)
Stomach cancer (4)
Supply chain (49)
Tariffs (34)
The Weekly (21)
Vaccines (679)
Venture capital (35)
Weight loss (121)
Women's health (46)
Worklife (9)
Date
Today (60)
Last 7 days (296)
Last 30 days (1091)
Last 365 days (17314)
2026 (1504)
2025 (17668)
2024 (20915)
2023 (24288)
2022 (33903)
2021 (35794)
2020 (33118)
2019 (27532)
2018 (20850)
2017 (19747)
2016 (19636)
2015 (23245)
2014 (17617)
2013 (15587)
2012 (15663)
2011 (16388)
2010 (15184)
Location
Africa (572)
Alabama (72)
Alaska (3)
Arizona (124)
Arkansas (5)
Asia (26109)
Australia (4948)
California (6024)
Canada (1986)
China (666)
Colorado (252)
Connecticut (291)
Delaware (178)
Europe (62162)
Florida (982)
Georgia (202)
Hawaii (1)
Idaho (31)
Illinois (485)
India (44)
Indiana (338)
Iowa (18)
Japan (302)
Kansas (57)
Kentucky (17)
Louisiana (14)
Maine (21)
Maryland (810)
Massachusetts (4431)
Michigan (203)
Minnesota (272)
Mississippi (4)
Missouri (79)
Montana (19)
Nebraska (14)
Nevada (54)
New Hampshire (28)
New Jersey (1943)
New Mexico (28)
New York (1924)
North Carolina (990)
North Dakota (7)
Northern California (2893)
Ohio (203)
Oklahoma (12)
Oregon (17)
Pennsylvania (1180)
Puerto Rico (6)
Rhode Island (27)
South America (624)
South Carolina (27)
Southern California (2413)
Tennessee (90)
Texas (1009)
United States (22620)
Utah (166)
Vermont (1)
Virginia (154)
Washington D.C. (55)
Washington State (594)
West Virginia (2)
Wisconsin (72)
Wyoming (1)
426,468 Results for "scripps research calibr division".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
November 20, 2025
·
6 min read
Press Releases
Functional Gut Clinic launches dedicated Clinical Trials Division to accelerate digestive health research
January 19, 2026
·
1 min read
Press Releases
Shift Bioscience Publishes Improved Metric Calibration Framework for Robust Genetic Perturbation Modeling Using AI Virtual Cells
November 11, 2025
·
2 min read
Press Releases
The IMA Group Clinical Research Division Continues Expansion with Acquisition of Chicago Research Center
October 8, 2025
·
3 min read
Business
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases
The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit drug development division of Scripps Research, announced today that AbbVie (NYSE: ABBV) has expanded its collaboration to further explore Calibr-Skaggs’ switchable CAR-T (sCAR-T) platform in solid tumor indications and autoimmune diseases.
February 6, 2024
·
3 min read
Press Releases
Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
July 24, 2025
·
6 min read
Press Releases
BridgeBio to Report Phase 3 Results for Encaleret in ADH1 CALIBRATE Study on Wednesday, October 29th
October 28, 2025
·
1 min read
Press Releases
Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at Scripps’ Structural Heart Intervention and Imaging 2026 Conference
February 5, 2026
·
2 min read
Biotech Beach
Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound
Calibr, a division of Scripps Research dedicated to the “bench to bedside” development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute, announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment.
February 15, 2023
·
4 min read
Career Advice
Going With the Flow: Finding Success in Academic and Biotech Research Cultures
At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific culture where you work.
January 21, 2026
·
6 min read
·
Manali Shah
1 of 42,647
Next
